| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
245,670,000 |
| Market
Cap: |
123.11(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0.3988 - $1.05 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Senseonics Holdings is a medical technology company focused on the development and manufacturing of implantable continuous glucose monitoring (CGM) system to improve the lives of people with diabetes. Co.'s Eversense, Eversense XL and Eversense E3 CGM system are designed to measure glucose levels in people with diabetes via an under-the-skin sensor, a removable and rechargeable smart transmitter, and an app for real-time diabetes monitoring and management for a period of up to six months, respectively. The Eversense system can be used as a therapeutic CGM in the U.S. to replace fingerstick blood glucose measurement to make treatment decisions, including insulin dosing.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
300,000 |
300,000 |
| Total Buy Value |
$0 |
$0 |
$162,000 |
$162,000 |
| Total People Bought |
0 |
0 |
1 |
1 |
| Total Buy Transactions |
0 |
0 |
1 |
1 |
| Total Shares Sold |
0 |
0 |
30,889 |
80,889 |
| Total Sell Value |
$0 |
$0 |
$18,842 |
$117,342 |
| Total People Sold |
0 |
0 |
1 |
2 |
| Total Sell Transactions |
0 |
0 |
1 |
2 |
| End Date |
2024-02-08 |
2023-11-07 |
2023-05-09 |
2022-05-09 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Tressler Nick B. |
Chief Financial Officer |
• – – |
2022-02-10 |
4 |
A |
$0.00 |
$0 |
D/D |
165,854 |
380,283 |
|
- |
|
| Horton Kenneth L |
GC & Corp. Development Advisor |
• – – |
2022-02-10 |
4 |
A |
$0.00 |
$0 |
D/D |
255,287 |
1,360,551 |
|
- |
|
| Jain Mukul |
Chief Operating Officer |
• – – |
2022-02-10 |
4 |
A |
$0.00 |
$0 |
D/D |
260,483 |
1,999,607 |
|
- |
|
| Kaufman Francine |
Chief Medical Officer |
• • – |
2022-02-10 |
4 |
A |
$0.00 |
$0 |
D/D |
310,884 |
1,386,045 |
|
- |
|
| Panlilio Mirasol |
VP Global Sales and Marketing |
• – – |
2022-02-10 |
4 |
A |
$0.00 |
$0 |
D/D |
210,020 |
1,189,548 |
|
- |
|
| Fiorentino Edward |
Director |
– • – |
2022-01-03 |
4 |
A |
$2.75 |
$14,124 |
D/D |
5,136 |
407,392 |
|
- |
|
| Steven Edelman |
Director |
– • – |
2022-01-03 |
4 |
A |
$2.75 |
$9,655 |
D/D |
3,511 |
389,594 |
|
- |
|
| Defalco Stephen P |
Director |
– • – |
2022-01-03 |
4 |
A |
$2.75 |
$24,998 |
D/D |
9,090 |
1,193,331 |
|
- |
|
| Prince Douglas S |
Director |
– • – |
2022-01-03 |
4 |
A |
$2.75 |
$9,375 |
D/D |
3,409 |
301,082 |
|
- |
|
| Larkin Sharon |
Director |
– • – |
2021-12-08 |
4 |
A |
$0.00 |
$0 |
D/D |
72,115 |
72,115 |
|
- |
|
| Raab Anthony R. |
Director |
– • – |
2021-12-06 |
4 |
AS |
$2.53 |
$345,441 |
D/D |
(136,538) |
217,022 |
|
-40% |
|
| Jain Mukul |
Chief Operating Officer |
• – – |
2021-11-16 |
4 |
AS |
$3.70 |
$370,000 |
D/D |
(100,000) |
1,739,124 |
|
-49% |
|
| Kaufman Francine |
Chief Medical Officer |
• • – |
2021-11-16 |
4 |
AS |
$3.70 |
$77,693 |
D/D |
(20,998) |
1,075,161 |
|
-49% |
|
| Tressler Nick B. |
Chief Financial Officer |
• – – |
2021-11-15 |
4 |
D |
$3.80 |
$29,830 |
D/D |
(7,850) |
214,429 |
|
- |
|
| Goodnow Timothy T |
President and CEO |
• • – |
2021-11-15 |
4 |
D |
$3.80 |
$1,132,381 |
D/D |
(297,995) |
4,528,908 |
|
- |
|
| Panlilio Mirasol |
VP Global Sales and Marketing |
• – – |
2021-11-15 |
4 |
D |
$3.80 |
$181,834 |
D/D |
(47,851) |
979,528 |
|
- |
|
| Jain Mukul |
Chief Operating Officer |
• – – |
2021-11-15 |
4 |
D |
$3.80 |
$437,524 |
D/D |
(115,138) |
1,839,124 |
|
- |
|
| Kaufman Francine |
Chief Medical Officer |
• • – |
2021-11-15 |
4 |
D |
$3.80 |
$211,018 |
D/D |
(55,531) |
1,096,159 |
|
- |
|
| Horton Kenneth L |
GC & Corp. Development Advisor |
• – – |
2021-11-15 |
4 |
D |
$3.80 |
$176,419 |
D/D |
(46,426) |
1,105,264 |
|
- |
|
| Steven Edelman |
Director |
– • – |
2021-10-01 |
4 |
A |
$3.45 |
$9,653 |
D/D |
2,798 |
386,083 |
|
- |
|
| Fiorentino Edward |
Director |
– • – |
2021-10-01 |
4 |
A |
$3.45 |
$14,124 |
D/D |
4,094 |
402,256 |
|
- |
|
| Prince Douglas S |
Director |
– • – |
2021-10-01 |
4 |
A |
$3.45 |
$9,374 |
D/D |
2,717 |
297,673 |
|
- |
|
| Defalco Stephen P |
Director |
– • – |
2021-10-01 |
4 |
A |
$3.45 |
$24,999 |
D/D |
7,246 |
1,184,241 |
|
- |
|
| Roeder Douglas A |
Director |
– • – |
2021-08-25 |
4 |
S |
$3.50 |
$755,115 |
D/D |
(215,747) |
60,483 |
|
25% |
|
| Roeder Douglas A |
Director |
– • – |
2021-08-25 |
4 |
OE |
$1.35 |
$345,155 |
D/D |
215,747 |
276,230 |
|
- |
|
341 Records found
|
|
Page 5 of 14 |
|
|
